Helixgate https://validator.w3.org/feed/docs/rss2.html STAT+: Publicly, Kennedy embraces a more moderate MAHA STAT+: Federal test of AI prior authorization is delaying care for seniors, report says OpenAI’s head of health lays out the AI giant’s healthcare ambitions Brain Astrocytes Form Far-Reaching Connections in Mice AbbVie’s North Carolina $1.4B manufacturing site to finish during Trump’s term STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more FDA issues warning letter after GLP-1 manufacturer refuses inspectors access Andelyn Partners with S. Korea-Based ENCell to Accelerate Global Delivery of Gene Therapies BridgeBio’s oncology spinoff swaps out CEOs as it seeks to accelerate KRAS work Live: Robert F. Kennedy Jr. testifies before Senate HELP committee Pharma-backed petition calls on FDA to reform release of drug rejection letters Viral Contamination Still a Challenge for CGT Industry Revolution drug shows promise in early pancreatic cancer Nektar’s $325M offering; Maze stock rises; Merck deal rumors; BMS layoffs Sanofi’s new CEO faces a reckoning on immunology-focused R&D strategy Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial Trump’s psychedelics push a mixed blessing for neuropsychiatric companies, patients Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors Tipping the genomic scales: Preparing for the integrated multiomics era STAT+: Pharmalittle: We’re reading about Medicare’s obesity drug pilot, an experimental Roche MS drug, and more The 4 biggest hiring mistakes biopharma executives keep making Ionis’ antisense drug stabilizes ultra-rare disease ahead of FDA decision Lilly exits Rigel alliance, adding to RIPK1 scrap heap Lilly, Novo dip as proposed Medicare coverage for GLP-1 pilot thrown off balance Amid US ordeal, Moderna wins EU approval for flu/COVID-19 combo shot Moderna continues bird flu vax study, but limits work in the U.S. Merck steps up as ‘meaningful competitor’ to Gilead with HIV pill approval Antigen‑Stabilized Nanobody Probes Enable On‑Demand, Multicolor Protein Imaging Are MAHA snacks really better for you? Nutrition experts parse a grocery aisle gold rush The 5 largest IPOs in biopharma history The next phase of diabetes care Denali CEO’s ‘greatest professional moment’ arrives as rare disease drug launches Why key opinion leader enthusiasm often doesn’t predict future commercial success #AAN26: Roche’s multiple sclerosis pill delays relapse, but liver toxicity could need monitoring STAT+: With successful trials, Roche takes its MS drug to regulators, but safety questions loom STAT+: From Revolution Medicines, more strong data on KRAS drug and a glimpse of a ‘novel class’ beyond it STAT+: Key GOP senators push back on Trump’s plan to cut NIH, reorganize HHS Medicare indefinitely delays pilot plan to cover weight loss drugs Alzheimer’s Linked to Cancer Mutations in Brain Immune Cells RFK Jr. says China is ‘eating our lunch’ in biotech advances Tortugas debuts with $106M and brain drugs from Hansoh, Eisai Merck’s Welireg combo fails in first-line kidney cancer Merck’s fast-ascending kidney cancer drug hits a setback UnitedHealth breaks down how it plans to spend $1.5B on AI Navigating with Excellence: The Multi-Faceted Service Lines of Precision Logistics FDA approves once-daily HIV pill from Merck Flu vaccine no longer mandated for U.S. troops, defense secretary says Nomic and Broad Clinical Labs to build proteomics platform  ‘It’s just the beginning’ for pancreatic cancer’s long-awaited breakthrough Home